Importance of World Glaucoma Day

Article

Your thoughts on the efficacy of initiatives such as World Glaucoma Day.

Key Points

World Glaucoma Day on March 12th saw huge participation amongst the ophthalmology community across both Europe and the rest of the world and the message from its organisers was clear - the role of the clinician in the early detection of glaucoma cannot be overemphasized. But what did you think?

"Glaucoma is a slowly progressive degeneration of the optic nerves. It is often (but not always) associated with elevated IOP. The vision loss in glaucoma occurs first in the periphery before involving the central vision. Patients are, therefore, unaware of the progressive loss of peripheral vision until the very advanced stages of the disease," said Dr. Ritchie, co-chairman of the World Glaucoma Day Committee of the World Glaucoma Association.

Effective screening for glaucoma includes some additional tests. "Of course, no examination is complete without darkroom gonioscopy to identify angle closure, IOP measurement, and examination of the optic nerves for disc haemorrhage, parapapillary atrophy, nerve fibre layer defects, and the appearance of the neuroretinal rim. Patients with risk factors for glaucoma or a suggestive clinical examination may then undergo the appropriate perimetric testing and imaging of the optic nerve head to assess the extent of disease. Stereoscopic disc photography in patients with glaucoma risk factors is a powerful tool to establish a baseline and detect future pre-perimetric glaucomatous change," noted Dr. Angelilli, a clinical instructor at the New York University Medical Centre.

If you are not already a member of the European ophthalmology community go to http://www.oteurope.com/forum/ or pose your questions to colleagues at http://www.oteurope.com/discuss/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.